MedTrace Logo

Quality of Telemedically Guided Prehospital Analgesia

NCT02928705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 381

Last updated 2016-10-10

No results posted yet for this study

Summary

The purpose of this retrospective study is to analyze quality and adverse events of analgesia by telemedically supported paramedics in comparison to conventional treatment by on-scene emergency medical service (EMS) physicians in the EMS of the city of Aachen, Germany.

Conditions

  • Analgesia
  • Prehospital
  • Telemedicine
  • Ambulance
  • Opioids
  • Teleconsultation
  • Tele-emergency Medical Services
  • Adverse Events
  • City of Aachen
  • Prehospital Emergency Medical Service Physician

Interventions

PROCEDURE

physician operated telemedical prehospital analgesia

Ambulances in the EMS of the city of Aachen are equipped with a portable telemedicine system. In emergencies requiring intravenous analgesia paramedics can use this system to contact the tele-EMS physician with an audio-connection. Vital parameters (e.g., ECG, pulse oximetry, non-invasive blood pressure) can be transferred in real-time. The transmission of still pictures - taken with an official smartphone - and video streaming from the inside of the ambulance are also possible. The tele-EMS physician supports the paramedics and can delegate the application of morphine and other analgesics based on two predefined algorithms for trauma and non-trauma cases that are displayed on a context-sensitive telemedical documentation system in the teleconsultation center.

PROCEDURE

prehospital analgesia by on-scene EMS physicians

This (control) group represents the conventional treatment in German emergency medical service (EMS). In addition to an ambulance manned with paramedics, a prehospital EMS physician is deployed to conduct analgesic treatment on-scene. Treatment data for this group are selected from the time period before implementing teleconsultation in routine and therefore represent a historical control group.

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Rolf Rossaint, Professor, MD · University Hospital, Aachen

  • Sebastian Bergrath, MD · University Hospital, Aachen

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-03-31
Completion
2016-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928705 on ClinicalTrials.gov